top of page
Profile
Join date: Feb 8, 2023
Posts (8)
Sep 5, 2023 ∙ 1 min
2023 CIMT Annual Meeting Poster Presentation
YB-200, a novel IgG1 antibody targeting CEACAM1/5, induces complete response in syngeneic liver Hepa1-6 tumor-bearing mice and modulates...
68
0
Apr 26, 2023 ∙ 1 min
Dr. Katrin Rupalla Interviewed by Global Business Reports
Life Sciences issue 2023 highlights companies making a difference with their research Read the full interview with Dr. Rupalla in which...
117
0
Apr 26, 2023 ∙ 2 min
Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Presentation to focus on mechanism of action of anti-tumor activity for lead asset YB-200 RIEHEN, SWITZERLAND, April 26, 2023 ─...
195
0
Kellyann Zuzulo
Admin
More actions
bottom of page